James B. Renacci bought Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 4 trades in Ligand Pharmaceuticals Incorporated (LGND) since 2015, all purchases, worth an estimated $57K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: James B. Renacci bought $15,001 - $50,000 of Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) on February 9, 2015. Since that trade, LGND is up +746.34% against the S&P 500 up +330.46%, an outperformance of +415.88%.
Across these filings, James B. Renacci has been a net buyer of LGND. The most recent disclosed LGND transaction shown was dated January 11, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's LGND trades vs the price
LGND is up +746.34% since James B. Renacci bought on February 9, 2015, versus +330.46% for the S&P 500.
Performance since this trade
All James B. Renacci LGND trades
| Traded | Type | Size | Return | Est. profit | |
|---|---|---|---|---|---|
| January 11, 2016 | BUY | $58.27 | +394.30% | +$17K | |
| August 24, 2015 | BUY | $51.89 | +455.04% | +$20K | |
| August 3, 2015 | BUY | $67.84 | +324.57% | +$13K | |
| February 9, 2015 | BUY | $34.03 | +746.34% | +$139K |
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
James B. Renacci & LGND trading FAQ
Is it legal for James B. Renacci to trade Ligand Pharmaceuticals Incorporated (LGND) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Ligand Pharmaceuticals Incorporated (LGND), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci buy LGND?
James B. Renacci disclosed a purchase of $15,001 - $50,000 of Ligand Pharmaceuticals Incorporated (LGND) on February 9, 2015, according to public STOCK Act filings.
How has LGND performed since James B. Renacci's trade?
Since James B. Renacci bought LGND on February 9, 2015, the stock is up +746.34%, versus +330.46% for the S&P 500 over the same period, an outperformance of +415.88%.
How many times has James B. Renacci traded LGND?
James B. Renacci has disclosed 4 LGND trades since 2015. Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional LGND trades?
Quantellect tracks every disclosed congressional trade in Ligand Pharmaceuticals Incorporated (LGND) on the Ligand Pharmaceuticals Incorporated congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's LGND tradesAll congressional filings for Ligand Pharmaceuticals IncorporatedJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.